Annual CAPEX
$12.55 M
-$24.81 M-66.40%
December 31, 2023
Summary
- As of February 12, 2025, RXRX annual capital expenditures is $12.55 million, with the most recent change of -$24.81 million (-66.40%) on December 31, 2023.
- During the last 3 years, RXRX annual CAPEX has risen by +$5.82 million (+86.37%).
- RXRX annual CAPEX is now -68.46% below its all-time high of $39.80 million, reached on December 31, 2021.
Performance
RXRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$4.56 M
+$380.00 K+9.09%
September 30, 2024
Summary
- As of February 12, 2025, RXRX quarterly capital expenditures is $4.56 million, with the most recent change of +$380.00 thousand (+9.09%) on September 30, 2024.
- Over the past year, RXRX quarterly CAPEX has dropped by -$2.09 million (-31.43%).
- RXRX quarterly CAPEX is now -76.50% below its all-time high of $19.42 million, reached on March 31, 2021.
Performance
RXRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$17.81 M
+$3.73 M+26.53%
September 30, 2024
Summary
- As of February 12, 2025, RXRX TTM capital expenditures is $17.81 million, with the most recent change of +$3.73 million (+26.53%) on September 30, 2024.
- Over the past year, RXRX TTM CAPEX has increased by +$3.95 million (+28.48%).
- RXRX TTM CAPEX is now -55.38% below its all-time high of $39.92 million, reached on September 30, 2021.
Performance
RXRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
RXRX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.4% | -31.4% | +28.5% |
| 3 y3 years | +86.4% | -42.8% | -52.3% |
| 5 y5 years | +221.0% | -42.8% | -52.3% |
RXRX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -68.5% | at low | -72.3% | +451.6% | -55.2% | +41.9% |
| 5 y | 5-year | -68.5% | +221.0% | -76.5% | +452.3% | -55.4% | +2056.7% |
| alltime | all time | -68.5% | +221.0% | -76.5% | +452.3% | -55.4% | +2056.7% |
Recursion Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.56 M(+9.1%) | $17.81 M(+26.5%) |
| Jun 2024 | - | $4.18 M(-37.1%) | $14.08 M(+1.5%) |
| Mar 2024 | - | $6.65 M(+175.3%) | $13.87 M(+10.5%) |
| Dec 2023 | $12.55 M(-66.4%) | $2.42 M(+192.3%) | $12.55 M(-30.7%) |
| Sep 2023 | - | $827.00 K(-79.2%) | $18.11 M(-29.9%) |
| Jun 2023 | - | $3.97 M(-25.7%) | $25.85 M(-32.6%) |
| Mar 2023 | - | $5.34 M(-33.1%) | $38.36 M(+2.7%) |
| Dec 2022 | $37.36 M | $7.98 M(-6.8%) | $37.36 M(+10.4%) |
| Sep 2022 | - | $8.56 M(-48.0%) | $33.84 M(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $16.48 M(+279.4%) | $34.99 M(+41.5%) |
| Mar 2022 | - | $4.34 M(-2.7%) | $24.72 M(-37.9%) |
| Dec 2021 | $39.80 M(+490.9%) | $4.46 M(-54.0%) | $39.80 M(-0.3%) |
| Sep 2021 | - | $9.71 M(+56.2%) | $39.92 M(+28.6%) |
| Jun 2021 | - | $6.21 M(-68.0%) | $31.05 M(+25.0%) |
| Mar 2021 | - | $19.42 M(+322.9%) | $24.83 M(+358.4%) |
| Dec 2020 | $6.74 M(+72.3%) | - | - |
| Dec 2020 | - | $4.59 M(+455.8%) | $5.42 M(+555.8%) |
| Sep 2020 | - | $826.00 K | $826.00 K |
| Dec 2019 | $3.91 M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual CAPEX year-on-year change?
- What is Recursion Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Recursion Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM CAPEX year-on-year change?
What is Recursion Pharmaceuticals annual capital expenditures?
The current annual CAPEX of RXRX is $12.55 M
What is the all time high annual CAPEX for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual capital expenditures is $39.80 M
What is Recursion Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, RXRX annual capital expenditures has changed by -$24.81 M (-66.40%)
What is Recursion Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of RXRX is $4.56 M
What is the all time high quarterly CAPEX for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly capital expenditures is $19.42 M
What is Recursion Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, RXRX quarterly capital expenditures has changed by -$2.09 M (-31.43%)
What is Recursion Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of RXRX is $17.81 M
What is the all time high TTM CAPEX for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM capital expenditures is $39.92 M
What is Recursion Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, RXRX TTM capital expenditures has changed by +$3.95 M (+28.48%)